stella
beta
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression — Stella
Recruiting
Back to Treatment-resistant Bipolar Depression trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
The University of Texas Health Science Center at Houston, Houston, Texas
View full record on ClinicalTrials.gov